The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 is set to fall 1.04% after a night of weakness on US markets.

On Thursday, the S&P 500 and Nasdaq both experienced dramatic falls – by 0.8% and 0.7% respectively – while the Dow fell back from its record highs, with a significant drop of 533 points. The falls were inspired by megacap tech stocks, but the sell-off extended to other sectors as most finished in the red.

Negative performances were reported by Apple (2%), Microsoft (0.7%), Alphabet (1.9%), and Amazon (2.1%), while some gains were made by Nvidia (2.5%) and Meta (3%). A decline on the healthcare sector was led by Eli Lilly, which dropped 6.2%. Netflix also dropped 0.7%.

Also overnight, the European central bank left rates on hold at 3.75%, but ECB president Christine Lagarde said a cut in September was a strong possibility.

Over at the ASX, NewPeak Metals Ltd (ASX:NPM) is set to acquire the Treur Range uranium-vanadium project in the Northern Territory.

Meanwhile, Argosy Minerals Ltd (ASX:AGY) has signed a Spot Sale Contract with a Korean chemical company, for the sale of 20 metric tonnes of battery-quality lithium carbonate produced from Argosy’s Rincon Lithium project in Argentina.

And online retailer Adore Beauty Group Ltd (ASX:ABY) has reported that its annual revenue for the 2024 financial year was up 7.4% on the prior corresponding period (PCP), to $195.7 million, while it also saw a record 519 thousand customers returning, a rise of 5.8% on PCP.

In forex, the Aussie is buying just over 67 US cents.

In commodities, brent crude fell 0.42% to US$84.72, while iron ore was down 0.41% to US$108.94 per tonne at Singapore.

Gold fell 0.68% to US$2,444 per ounce while US natgas futures are at US$2.10 per gigajoule.

More From The Market Online

KGL Resources jumps 25% on US$300M funding deal

KGL Resources has entered into a US$300 million PMPA to help fund construction and development of…
London

With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London

Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment

Terra hits multiple intersections at Southwest SW6 prospect; assays now due in next ~12 weeks

Terra Metals has hit multiple intersections of massive sulphides in drilling at the Southwest SW6 prospect…

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk